Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-01-14 06:06 am Sale |
2021-12-31 | 13G | Shattuck Labs, Inc. STTK |
TAKEDA PHARMACEUTICAL CO LTD | 2,090,858 4.950% |
-9,454 (-0.45%) |
Filing History |
| 2022-01-14 06:02 am Purchase |
2021-12-31 | 13G | Day One Biopharmaceuticals, Inc. DAWN |
TAKEDA PHARMACEUTICAL CO LTD | 6,012,758 9.700% |
6,012,758 (New Position) |
Filing History |
| 2021-11-12 06:03 am Sale |
2021-11-09 | 13D | Phathom Pharmaceuticals, Inc. PHAT |
TAKEDA PHARMACEUTICAL CO LTD | 7,459,304 19.200% |
-1,212,696 (-13.98%) |
Filing History |
| 2021-10-25 06:07 am Sale |
2021-10-19 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
TAKEDA PHARMACEUTICAL CO LTD | 530,562 1.700% |
-1,328,589 (-71.46%) |
Filing History |
| 2021-10-18 06:03 am Sale |
2021-10-14 | 13G | BiomX Inc. PHGE |
TAKEDA PHARMACEUTICAL CO LTD | 147,829 5.200% |
-99,265 (-40.17%) |
Filing History |
| 2021-09-14 06:13 am Sale |
2021-08-24 | 13D | Molecular Templates, Inc. MTEM |
TAKEDA PHARMACEUTICAL CO LTD | 154,311 4.100% |
-40,556 (-20.81%) |
Filing History |
| 2021-08-30 06:07 am Sale |
2021-07-22 | 13G | HOOKIPA Pharma Inc. HOOK |
TAKEDA PHARMACEUTICAL CO LTD | 29,069 1.100% |
-104,290 (-78.20%) |
Filing History |
| 2021-04-06 06:05 am Unchanged |
2021-04-02 | 13D | Phathom Pharmaceuticals, Inc. PHAT |
TAKEDA PHARMACEUTICAL CO LTD | 8,672,000 22.300% |
0 (Unchanged) |
Filing History |
| 2021-04-01 06:06 am Unchanged |
2021-03-31 | 13D | Phathom Pharmaceuticals, Inc. PHAT |
TAKEDA PHARMACEUTICAL CO LTD | 8,672,000 22.300% |
0 (Unchanged) |
Filing History |
| 2021-02-05 06:10 am Purchase |
2020-12-31 | 13G | Takeda Pharmaceutical Company Limited TAK |
Sumitomo Mitsui Trust Group, Inc. | 94,034,034 6.000% |
94,034,034 (New Position) |
Filing History |
| 2021-02-01 08:17 am Sale |
2020-12-31 | 13G | Takeda Pharmaceutical Company Limited TAK |
BLACKROCK INC BLK |
99,548,936 6.300% |
-1,779,055 (-1.76%) |
Filing |
| 2021-01-29 06:06 am Purchase |
2020-12-31 | 13G | Shattuck Labs, Inc. STTK |
TAKEDA PHARMACEUTICAL CO LTD | 2,100,312 5.060% |
2,100,312 (New Position) |
Filing History |
| 2021-01-28 5:57 pm Sale |
2020-12-31 | 13G | Quince Therapeutics, Inc. QNCX |
TAKEDA PHARMACEUTICAL CO LTD | 87,258 0.300% |
-2,592,544 (-96.74%) |
Filing History |
| 2021-01-27 06:02 am Unchanged |
2020-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
TAKEDA PHARMACEUTICAL CO LTD | 1,859,151 7.200% |
0 (Unchanged) |
Filing History |
| 2021-01-25 06:07 am Sale |
2020-12-31 | 13G | Telesis Bio, Inc. TBIO |
TAKEDA PHARMACEUTICAL CO LTD | 0 0.000% |
-393,275 (Position Closed) |
Filing History |